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ABSTRACT  
Background 
In recent years, there has been an increase in prescription drug abuse, particularly among 
adolescents and young adults.  While substance abuse on college campuses has remained a 
pervasive public health concern, rates of nonmedical prescription drug use surpass commonly 
abused drugs.  The three most commonly abused prescription drugs (central nervous system 
(CNS) depressants, opioids, and stimulants) were assessed to identify differences among student 
characteristics, as well as their relationship with abuse.   
 
Purpose  
The purpose of this study is to conduct a secondary analysis to explore demographic variables 
(race, gender, academic performance, living arrangement, alcohol and other drug usage, and 
affiliation with a fraternity/sorority) and their relationship with nonmedical prescription drug use.  
Also, this study aims to identify potential strategies and provide suggestions to address 
nonmedical prescription drug abuse for future interventions.  
 
Methods 
Data was obtained from the 2009 National College Health Assessment.  The study consisted of n 
= 1,417 undergraduate students attending Virginia Commonwealth University.  Initially, overall 
prevalence rates for past-year illicit use of prescription CNS depressant, opioids, and stimulant 
use were examined.  Bivariate analyses were conducted to identify differences among users and 
nonusers for each class of prescription drug using Pearson’s Chi-Square test of significance. 
Multiple logistic regressions were used to examine associations between these demographics and 
illicit use of each prescription drug. Interactions between individual demographics and drug use 
were also examined. 
 
Results  
The past year prevalence use of nonmedical prescription central nervous system depressants, 
opioids, and stimulants use were 4, 11.2, and 8.7% respectively.  According to bivariate 
analyses, nonmedical use was higher among certain college students, however characteristics 
varied by type of prescription drug.  Multiple logistic regression analyses indicated that students 
living off campus (OR = 2.12, 95% CI = 1.03, 4.35) and reported use of alcohol (OR = 3.91, 
95% CI = 1.21, 12.64) and marijuana (OR = 4.41, 95% CI = 2.28, 8.54) were more likely to use 
prescription depressants.  Students with a GPA of a C or lower (OR = 1.50, 95% CI = 1.03, 
2.17), and reported use of marijuana (OR = 3.25, 95% CI = 2.22, 4.78) were more likely to use 
prescription opioids.  Nonmedical prescription stimulant use was highest among White students 
(OR = 2.02, 95% CI = 1.28, 3.30) with a GPA of a B or lower (OR = 2.06, 95% CI = 1.28, 3.30) 
and reported lifetime use of alcohol (OR = 7.96, 95% CI = (2.50, 25.41).  
 
Conclusions  
The results of this study provide insight into the demographic variables and their relationship 
with nonmedical prescription drug abuse.  The findings have important implications for 
identifying potential strategies to address nonmedical prescription drug abuse and will assist in 
the development of targeted and tailored interventions.  
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INTRODUCTION  
The abuse of alcohol and drugs on college campuses remains a pervasive public health 
concern.  While alcohol and cigarettes have shown significant changes in use throughout the 
intervening decades, many new illicit drugs have emerged, including the use of nonmedical 
prescription drugs (Johnston, O'Malley, Bachman, & Schulenberg, 2009).  Nonmedical use of 
prescription drugs is defined as use without a legitimate prescription or inconsistent with a 
doctor’s instructions (Hamilton, 2009).  An estimated 48 million people (ages 12 and older) have 
used prescription drugs for nonmedical reasons in their lifetime, constituting roughly 20% of the 
U.S. population (Volkow, 2009).  In a single survey, first-time nonmedical use of pain relievers 
was reported by 2.2 million people aged 12 years or older (Hamilton, 2009).  Between 1992 and 
2003, the use of nonmedical prescription drugs among 12 to 17 year olds increased 212% (Ford 
& Schroeder, 2008).  This issue has received significant public health attention during the past 
15 years and has developed into a concerning trend among college students (Garnier, O’Grady, 
& Wish, 2009).  
  The annual prevalence of nonmedical use of any prescription drug (i.e., stimulants, 
opioids, sedatives, or tranquilizers) among U.S. college students increased from 8.3% in 1996 to 
14.6% in 2006.  Over the same time period, the prevalence of marijuana declined, indicating a 
shift in drug abuse among students (McCabe, 2007).  The three classes of prescription drugs that 
are most commonly abused are central nervous system (CNS) depressants, opioids, and 
stimulants (National Institute on Drug Abuse [NIDA], 2009).  The safety of these prescription 
medications is often misconstrued as they are known for their therapeutic benefits, however they 
are extremely addictive and misuse can result in serious health consequences (Hamilton, 2009; 
NIDA, 2009).   
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Commonly Abused Prescription Drugs  
CNS depressants are used to treat anxiety and sleep disorders.  Commonly prescribed 
depressants include Amytal, Valium, and Xanax.  Side effects include impaired coordination and 
dizziness however, when used at unprescribed rates, or combined with other substances that 
depress functioning, including alcohol, heart rate and respiration can slow down dangerously.  
Abuse of these medications can result in cardiac arrest and potentially death (NIDA, 2009).   
Opioids, also known as prescription narcotics or pain killers, are prescribed for their 
effective pain-relieving qualities.  Commonly prescribed opioids include OxyContin, Percodan, 
and Percocet.  Opioids are highly addictive and side effects include drowsiness, nausea, 
constipation, and, depending upon the amount taken, depressed respiration (NIDA, 2009).  
Opioids also have dangerous combination effects, particularly when consumed with alcohol, 
which increases respiratory distress (NIDA, 2009).   
The third most commonly abused class of prescription drugs are stimulants which are 
often used to prescribe certain sleep disorders and attention deficit hyperactivity disorder 
(ADHD).  Common stimulants such as Ritalin and Adderall, are mistakenly perceived as safe, 
and are used nonmedically to improve academic performance or cause weight loss (Hamilton, 
2009).  However, taken repeatedly or in high doses, stimulants can cause anxiety, paranoia, 
dangerously high body temperatures, irregular heartbeat, or seizures (NIDA, 2009). 
 As awareness of their side effects and access has increased, prescription drugs have 
become a significant public health concern.  Students are not only using these drugs for 
recreational purposes, but also to help with concentration when cramming for papers or tests, to 
self-medicate for anxiety or depression, and even to enhance their stamina when playing sports 
(Higher Education Center for Alcohol, Drug Abuse, and Violence Prevention, 2010).  It is 
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critical that health professionals understand the risk factors associated with nonmedical 
prescription drug use to correct student’s misperceptions and reduce use on college campuses 
(Hamilton, 2009; McCabe, 2008).  
 The purpose of this study is to identify risk factors for nonmedical prescription CNS 
depressant, opioid, and stimulant use among college students to create effective health 
interventions to reduce abuse on campus.  Prescription drug abuse is a growing concern, 
therefore information regarding race, gender, academic performance (measured by grade point 
average, GPA), living arrangement, alcohol and other drug usage, and affiliation with a 
fraternity/sorority will assist health professionals in addressing this public health issue.  This 
research will identify student characteristics that are associated with increased likeliness of abuse 
and offer strategies for the creation of effective interventions.  
Specific Aims: 
o Explore the demographic variables (race, gender, academic performance, living 
arrangement, alcohol and other drug usage, and affiliation with a fraternity/sorority) 
associated with nonmedical prescription drug use. 
o Explore the relationship between race, gender, academic performance, living 
arrangement, alcohol and other drug usage, and/or affiliation with a fraternity/sorority 
and nonmedical prescription drug use.  
o Identify potential strategies and provide suggestions to address nonmedical 
prescription drug abuse for tailored and targeted interventions.  
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LITERATURE REVIEW 
Prescription medications provide invaluable relief to countless people with health 
problems, and when taken appropriately can improve the quality and length of life (NIDA, 
2009).  Regrettably, the nonmedical use of prescription drugs is a serious and growing public 
health problem in this country, especially among college students (Ford & Schroeder, 2008; 
Hamilton, 2009; Garnier et al., 2009).  The College Alcohol Study reported significant increases 
in the prevalence of nonmedical prescription drug use between 1993 and 2001 across several 
types of prescription medication (Ford & Schroeder, 2008).  Furthermore, a comparison of 
survey summaries between 2002 and 2005 revealed an increase in intentional abuse of 
prescription medications among college students from 5.4% to 6.3% (Hamilton, 2009).  Current 
past-year use estimates among college students range from 7% to 9%, with lifetime use ranging 
between 12% and 14% (Garnier et al., 2009). 
The National Institute on Drug Abuse’s categories of prescription drugs with potential for 
abuse includes dissociative anesthetics, opioids and morphine derivatives, stimulants, anabolic 
steroids, tranquilizers, sedative-hypnotics, and muscle relaxers.  These drugs are generally 
recognized as addictive, with the potential for users to develop tolerance to the medication, as 
well as withdrawal syndrome (Hamilton, 2009).  The three classes of prescription drugs that are 
most commonly abused are central nervous system (CNS) depressants, opioids, and stimulants 
(NIDA, 2009).  The annual prevalence of nonmedical use of any type of prescription drug in the 
general population (individuals aged 18 to 25) is 15.5%.  Reflecting national trends, the annual 
prevalence of use among U.S. college students increased from 8.3% in 1996 to 14.6% in 2006 
(McCabe, 2008).  Specifically, the prevalence rate for illicit use within the past year among 
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college students was highest for pain medication, followed by stimulant medication, sedative or 
anxiety medication, and sleeping medication (McCabe, Teter, & Boyd, 2006).  
CNS Depressants 
 
Central Nervous System (CNS) depressants are medications that slow brain function.  In 
higher doses, some CNS depressants, including tranquilizers and sedatives, can be used as 
general anesthetics or preanesthetics.  Based on their chemistry and pharmacology, CNS 
depressants are divided into three categories: barbiturates, benzodiazepines, and newer sleep 
medications (NIDA, 2009).  Barbiturates, such as mephobarbital (Mebaral) and sodium 
pentobarbital (Nembutal), are used as preanesthetics, promoting sleep.  Benzodiazepines, such as 
diazepam (Valium), alprazolam (Xanax), and estazolam (ProSom), are most commonly used to 
treat anxiety, acute stress reactions, panic attacks, convulsions, and sleep disorders.  They are 
usually prescribed only for short-term relief of sleep problems due to the risk of developing 
tolerance and addiction.  Newer sleep medications, such as zolpidem (Ambien) and eszopiclone 
(Lunesta), are now more commonly prescribed to treat sleep disorders as they act on a subset of 
the receptors in the brain, lowering the risk for abuse and addiction (NIDA, 2009).   
Most of the CNS depressants enhance the actions of the neurotransmitter gamma-
aminobutyric acid (GABA), which works by decreasing brain activity.  Although the classes of 
CNS depressants work in different ways, it is ultimately their ability to increase GABA activity 
that produces a calming or drowsy effect (NIDA, 2009).  
 Benzodiazepines are the most widely used anxiolytic medications due to their well-
established efficacy in the treatment of anxiety disorders.  There has been a recent increase in the 
U.S. prescription rates for benzodiazepines in general and for benzodiazepine anxiolytics among 
youths 20 years and younger specifically.  An increase in prescription rates may increase the 
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likelihood that these medications will be misused for their calming effects (NIDA, 2009; 
McCabe, 2005).  
Overdose of CNS depressants can cause severe breathing problems and potentially lead 
to death, particularly when these drugs are combined with other medications or alcohol (NIDA, 
2009).  The Drug Abuse Warning Network (DAWN), recently found benzodiazepines to be one 
of the most frequently reported prescription medications in emergency room drug-abuse related 
cases.  According to DAWN data, emergency department mentions of benzodiazepines 
significantly increased (38%) between 1995 and 2002.  In particular, mentions of alprazolam 
(Xanax) increased 62% and mentions of clonazepam (Klonopin) increased 33% over a similar 
time frame (McCabe, 2005) 
National epidemiological studies, national surveillance reports, and college-based studies 
provide strong evidence that the nonmedical use of prescription benzodiazepine anxiolytics is 
increasing among young adults and college students.  The Harvard School of Public Health 
College Alcohol Study (CAS) reported that the past year nonmedical use of benzodiazepine 
anxiolytics more than doubled between 1993 and 2001 (1.8% and 4.5%, respectively) in the past 
decade among U.S. college students (McCabe, 2005).  Recent studies indicate that the 
nonmedical use of prescription benzodiazepine anxiolytics among college students is at its 
highest level in the past two decades, with 1 in every 10 college students report nonmedical use 
of these drugs in their lifetime (McCabe, 2005). 
Opioids 
Opioids, also known as prescription narcotics or pain killers, are prescribed for their 
effective pain-relieving qualities.  Commonly prescribed opioids include morphine (e.g., Kadian, 
Avinza), codeine, and oxycodone (e.g., OxyContin, Percodan, Percocet).  Opioids affect the 
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brain and body by attaching to proteins called opioid receptors, found in the brain, spinal cord, 
and gastrointestinal tract.  Once attached, these drugs can block the perception of pain.  Side 
effects of opioids include drowsiness, nausea, constipation, and, depending upon the amount 
taken, depress respiration (NIDA, 2009).  
Nonmedical use of opioids is common because if their euphoric effects which impact the 
regions of the brain that perceive pleasure.  Euphoric effects are often intensified when 
administered by routes other than those recommended, such as snorting or injecting.  This also 
increases the risk for serious medical consequences, such as opioid overdose (NIDA, 2009). 
 When taken as directed, opioids can be used to manage pain effectively; however long-
term use of opioids can lead to physical dependence and addiction (NIDA, 2009).  Opioid-based 
medications may cause abnormally slow speech, reaction time, and movements, as well as 
confusion and disorientation.  Abusers typically appear apathetic, lethargic, and/or sleepy.  
Taking a large single dose of an opioid may result in severe respiratory depression which can 
lead to death (NIDA, 2009).  
Currently, approximately 1 in every 10 Americans between the ages of 18 and 25 report 
the nonmedical use of opioid analgesics in the past year.  Among four different classes of 
psychotherapeutic drugs (opioid analgesics, tranquilizers, stimulants, and sedatives), opioid 
analgesics was the class with the greatest nonmedical use, abuse, and dependence according to 
the 2001 National Household Survey on Drug Abuse (McCabe, Teter, Boyd, Knight, & 
Wechsler, 2005a).  
The 2002 National Survey on Drug Use and Health found that more than half (55%) of 
admissions to emergency departments involved prescription narcotics (Hamilton, 2009).  In 
addition, the 2006 DAWN data indicated that the overall mention of opioid analgesics 
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combinations by emergency departments significantly increased from 1995 to 2002 by 163%.  
Emergency department visits naming hydrocodone combinations also increased 160% in 2002 
with hydrocodone the most commonly reported pain reliever (McCabe et al., 2005a).  
Numerous studies have been published reporting the growing trends of prescription 
opioid use on college campuses, with lifetime prevalence of use around 12% and past year 
prevalence around 7% (McCabe et al., 2005a).  The life-threatening side effects associated with 
opioid use provide strong rationale for public health professionals to understand the reasons and 
patterns associated with use (Hamilton, 2009).  
Stimulants  
 Stimulants are frequently prescribed to increase alertness, attention, and energy.  
Stimulants have been used to treat a variety of disorders including asthma, obesity, and 
neurological disorders, however, as their potential for abuse and addiction became increasingly 
evident, the medical use of stimulants began to decline.  Currently, stimulants are prescribed for 
the treatment of only a few health conditions, including narcolepsy, depression, and most 
notably, ADHD (NIDA, 2009).  
Stimulants, such as dextroamphetamine (e.g., Dexedrine and Adderall) and 
methylphenidate (e.g., Ritalin and Concerta) resemble the chemical structures of the brain 
neurotransmitter monoamines, which includes norepinephrine and dopamine.  Stimulants 
enhance the effects of these neurotransmitters in the brain, which is often associated with a sense 
of euphoria.  However, stimulants also increase blood pressure and heart rate, and constrict blood 
vessels (NIDA, 2009).  
Adverse effects of stimulants include headaches, anxiety, anorexia, gastrointestinal 
distress, and sleeping problems (Hamilton, 2009).  Abusers appear to have boundless energy and 
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may display irritability, paranoia, and anger with some reporting hallucinations in the form of 
amphetamine psychosis (NIDA, 2009).  
As with other drugs of abuse, it is possible to become dependent upon or addicted to 
stimulants.  Repeated use of stimulants over a short period can lead to feelings of hostility or 
paranoia (NIDA, 2009).  Prescriptive stimulants have a black box warning mandated by the U.S. 
Food and Drug Administration because they can cause cardiovascular problems (Hamilton, 
2009).  Taking high doses of a stimulant may result in dangerously high body temperature and an 
irregular heartbeat, with the potential for cardiovascular failure or lethal seizures (NIDA, 2009).  
Studies have indicated a rise in the prescribing of psychoactive medications in the United 
States, including amphetamines and other stimulant medications.  This rise may be attributable to 
increased awareness of the disorder.  While these are effective treatments for ADHD, there is a 
growing concern regarding the potential abuse of these medications.  In a study by McCabe et 
al., (2005b), approximately 6.9% of college students reported lifetime nonmedical use, with 
4.1% reporting use in the past year (McCabe, Knight, Teter, & Wechsler, 2005b).  Furthermore, 
the Monitoring the Future Study reported higher rates of nonmedical Ritalin among college 
students when compared to their peers not attending college (Substance Abuse and Mental 
Health Services Administration [SAMHSA], 2009; McCabe et al., 2005b).  College students 
aged 18 to 22 were twice as likely as their counterparts (who were not full time college students) 
to report past year nonmedical use of Adderall.  They were also 5 times more likely to have used 
prescription pain relievers nonmedically (SAMHSA, 2009).   
Illicit use of prescription stimulants by college students is primarily through oral 
administration.  Motives of stimulant use most commonly reported were to help with 
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concentration and alertness when studying.  Reported less often were to get “high” and 
experimentation (Hamilton, 2009).  
Risk Factors for Abuse  
Compared to the understanding of tobacco and alcohol use on college campuses, 
knowledge on the risk factors and use of prescription drugs is lacking.  The minimal 
epidemiological research presents a need to accurately assess the characteristics of those 
individuals most at risk for nonmedical use of prescription drugs (McCabe et al., 2005a).  Recent 
research has identified characteristics of collegiate nonmedical prescription CNS depressant, 
opioid, and stimulant users, noting differences in race, gender, academic performance, and living 
arrangement (McCabe et al., 2005a; McCabe et al., 2005b; McCabe, 2008).  While many 
characteristics are known, there remains a need to more accurately identify the risk factors and 
trends associated with nonmedical use.  
Race  
Nonmedical prescription drug use has been found to vary among race/ethnicity.  Recent 
studies indicate that prescription drug use is much more prevalent among White students than 
students of a different race or ethnicity.  Specifically, nonmedical use of depressants was higher 
among White college students.  In addition, nonmedical use of prescription benzodiazepine 
anxiolytics was less likely to occur among college students who were Asian, and Hispanic 
(McCabe, 2005).   
Studies also note racial differences among prescription opioid users.  McCabe et al., 
(2005a) found that White students were over two times more likely than African-American and 
Asian college students to report nonmedical use of prescription opioid analgesics.  These higher 
rates of nonmedical use found among White college students compared to other racial groups 
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also parallel recent racial differences identified among high school seniors (McCabe et al., 
2005a).  
Nonmedical stimulant use also varies by student’s race/ethnicity.  White students were 
more likely than Asian and African American students to report nonmedical use of stimulants in 
both past year and past month prevalence (McCabe et al., 2005b).  
Gender  
The Monitoring the Future Report indicates that males are more likely to use most illicit 
drugs, with the differences seeming to be largest at the higher frequency of use levels.  
Specifically, gender differences in prescription drug abuse have been noted in various studies 
(Johnston et al., 2009). 
In a study by McCabe et al., (2005b), after adjusting for a number of predictors including 
race, age, living arrangement, grade point average, college men were almost two times more 
likely than women to report non-medical use of prescription stimulants.  Furthermore, 
experimentation with stimulants was reported as reason for abuse by 34.6% of men versus 18.2% 
of women whereas women were more likely than men report using prescription stimulants to 
lose weight, to help study, and to help increase alertness (Teter, McCabe, LaGrange, Cranford, & 
Boyd, 2006). 
Although the actual past-year prevalence for non-medical use of prescription opioids did 
not differ by gender (men = 7.4% and women = 7.5%), undergraduate women perceived the 
past-year prevalence to be significantly higher than their male counterparts (McCabe, 2008). 
Academic Performance   
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Prior research has indicated that college students often turn to illicit drugs and or alcohol 
in response to stress in academic settings (Ford & Schroeder, 2008).  Specifically, past year 
depressant use varied significantly as a function of grade point average (GPA) (McCabe, 2005).   
A 2005 study by McCabe et al. found that students who earned a B or lower were almost 
two times more likely to report nonmedical use prescription opioids when compared to students 
with higher grade point averages (McCabe et al., 2005a). 
Furthermore, students who had a B or lower grade point average were almost two times 
more likely to report nonmedical stimulant use when compared to students with a B+ average or 
higher.  Additional research has indicated that the most commonly reported motives for illicit 
stimulant use were to concentrate (65.2%), help study (59.8%) and increase alertness (47.5%) 
(Teter, et al., 2006). 
Living Arrangement 
A student’s living conditions can significantly impact the availability and perception of 
substances.  In a longitudinal study from 1997 to 2001, commuter status was significantly 
associated with nonmedical prescription drug abuse (McCabe, West, & Wechsler, 2007).   
Additionally, students residing in off-campus housing and fraternity and sorority houses 
were almost two times more likely than students living on campus to use opioids nonmedically 
(McCabe et al, 2005a).   
Similarly, students living in a fraternity or sorority house were significantly more likely 
to use stimulants when compared to students living in same-sex residence halls (McCabe et al., 
2005b). 
Alcohol and other drug use   
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Rates of prescription drug abuse are higher among students who use other substances 
such as alcohol and marijuana, as well as those who engage in risky behaviors.  The odds of 
reporting use of 3,4-methylenedioxymethamphetamine (Ecstasy) was more than 14 times greater 
among past-year nonmedical users of prescription drugs compared with college students who did 
not use prescription drugs in the past year.  The findings of this study provide compelling 
evidence that nonmedical users of prescription drugs are at substantially higher risk of a positive 
screening result for drug abuse (McCabe, 2008).  
Nonmedical benzodiazepine anxiolytic users were over four times more likely than 
students who had not used benzodiazepine anxiolytics nonmedically to report past month 
cigarette use and frequent binge drinking in the past 2 weeks.  Users were also over 10 times 
more likely to report past month and past year use of cocaine, ecstasy, and prescription 
stimulants.  Most notably, nonmedical benzodiazepine anxiolytic users were over 30 times more 
likely to report past year nonmedical use of prescription opioid analgesics (OR = 32.13, 
p < 0.001) (McCabe, 2005). 
Nonmedical prescription opioid users were over 4 times more likely to report frequent 
binge drinking, over 8 times more likely to report marijuana use in the past year, and over 13 
times more likely to report cocaine use in the past year.  Furthermore, users were four times 
more likely to report driving after binge drinking, and almost six times more likely to report 
being a passenger with a drunk driver than college students who had not abused prescription 
opioids.  This is particularly concerning as opioids, even in small, monitored doses can have an 
increased the risk of injury or medical emergency.  Yet when combined with other drugs, such as 
alcohol which is also a depressant, there is an increased risk for severe psychomotor impairment, 
respiration depression, unconsciousness, and death (Garnier et al., 2009).  
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Nearly 90% of full-time college students who used Adderall nonmedically in the past 
year were past month binge alcohol consumers, and more than 50% were heavy alcohol users 
(SAMHSA, 2009).  Nonmedical use of prescription stimulants is related to substance use and 
risky behaviors.  Students reporting nonmedical use of stimulants were 10 times more likely to 
report marijuana use in the past year, 7 times more likely to be a binge drinker, and 20 times 
more likely to report cocaine use (McCabe et al., 2005b).  
Affiliation with a Fraternity/Sorority  
Fraternity and sorority membership can play a significant role in a student’s perceptions 
and access to substances, including prescription drugs.  Previous research has noted that 
nonmedical past month use of prescription benzodiazepine anxiolytics differed significantly as a 
function of fraternity/sorority membership.  Past-year non-medical use of prescription stimulants 
was significantly more prevalent among fraternity/sorority members (12.0%) compared to non-
members (5.0%).  Similarly, fraternity/sorority members also perceived a higher rate of non-
medical prescription stimulant use compared to non-members (McCabe, 2008). 
Restatement of Specific Aims 
The purpose of this study is to examine risk factors for nonmedical prescription drug 
abuse and their relationship with use of depressants, opioids, and stimulants.  Virginia 
Commonwealth University has not previously assessed prescription drug use among its students 
therefore, this improved understanding will assist in the creation of effective health programs 
aimed at preventing and reducing use on campus.  
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METHODS 
 
The purpose of this study is to conduct a secondary analysis of survey data collected 
during February 2009 at Virginia Commonwealth University (VCU).  The study population 
consists of n = 1,417 randomly selected VCU undergraduate students in February 2009.  
Study Design 
 The ACHA-NCHA II was approved by the institutional review board at a large, urban 
university and was conducted during February 2009.  A random sample of 5,238 undergraduate 
and graduate students was drawn from a total population of 29,513.  The random sample 
received a letter notifying students of their selection for the study.  The letter described the study 
and informed students that they would soon receive an email that contained a self-administered 
confidential web survey; similar methods have proved to be effective for conducting research on 
alcohol and drug use among college students (Pealer, Weiler, Pigg, Miller, Forman, 2001).  
Following the initial letter and email, nonrespondents were sent up to two reminder emails.  
Participants were eligible to win prizes including a Nintendo Wii, Starbucks gift cards, and VCU 
t-shirts.  The final response rate was 36.4%.   
Study Instrument 
  The American College Health Association-National College Health Assessment II 
(ACHA-NCHA II) was used to survey students.  The survey contains 65 multiple choice 
questions on 8 content areas including: Health, Health Education, and Safety; Alcohol, Tobacco, 
and Drugs; Sex Behavior and Contraception; Weight, Nutrition, and Exercise; Mental Health; 
Physical Health; Impediments to Academic Performance; and also assesses demographic 
characteristics.  An additional 14 questions were added to assess VCU specific health promotion 
campaigns and services.   
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Demographics 
Respondents were asked to provide demographic information, including their 
race/ethnicity and gender.  
Student Characteristics 
Participant’s academic performance was assessed in the survey.  Students were asked, 
“What is your approximate cumulative grade point average,” with responses ranging from (1) A 
to (5) N/A.  Student’s living arrangement was also assessed with responses ranging from (1) 
campus residence hall to (6) other.  Student’s affiliation with a fraternity or a sorority was also 
assessed. 
Nonmedical use of prescription drugs 
Respondents were asked, “Within the last 12 months, have you taken any of the 
following prescription drugs that were not prescribed to you?”  The scale included “No” and 
“Yes” and listed sedatives (e.g., Xanax, Valium), pain killers (e.g., OxyContin, Vicodin, 
Codeine), and stimulants (e.g., Ritalin, Adderall).  
Alcohol Use 
Alcohol use was assessed with the question, “Within the last 30 days, on how many days 
did you use alcohol?”  The response scale ranged from (1) Never used to (8) Used daily.  
Respondents were also assessed on their alcohol consumption behaviors; “In the last two weeks 
how often did you consume more than 5 drinks in one setting,” with responses ranging from (1) 
N/A, don’t drink to (12) 10 or more times.  
Other Drug Use  
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Other drug use was assessed by past 30 day use of marijuana. Respondents answered the 
question, “Within the last 30 days, on how many days did you use marijuana?”  The response 
scale ranged from (1) Never used to (8) Used daily.  
Sample 
The final sample included n = 1,417 undergraduate students.  Only students who were 18 
years or older are included in the sample.  This sample was cleaned to only include 
undergraduate students.   
The mean age of the sample population was 21.62 years (SD = 5.13).  Females 
constituted 67.7% (n = 960) of the sample, compared to 31.6% (n = 448) of males.  The majority 
of the sample was White, non-Hispanic (67.2%, n = 952) followed by 14.8% (N = 210) 
identifying as Black, non-Hispanic and 12.3% (n = 174) Asian or Pacific Islander.  Almost all 
survey participants were full time students (92.2%, n= 1,306).  The majority of students 
completing the survey lived off campus without their parents (49.8% n = 705) reflecting VCU’s 
high commuter population.  Students living in campus residence halls constituted 27% (n =382) 
of the sample, and 17.1% (n = 242) lived off campus with a parent or guardian.  Of the total 
sample, 23.8% (n = 337) were first year students, 22.9% (n = 325) were second year students, 
24.0% (n = 340) were third year and 19.9% (n = 282) were fourth year students.  
Statistical Analysis 
All statistical analyses were conducted using Predictive Analytics SoftWare (PASW) 
Statistics version 18.  Overall prevalence rates for lifetime and past-year illicit use of prescription 
CNS depressant, opioid, and stimulant use were examined.  Bivariate analyses were conducted 
for each prescription drug and individual student characteristics (e.g., race, gender, academic 
performance, living arrangement, use of alcohol and marijuana, and fraternity/sorority 
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affiliation) using Pearson’s Chi-Square test of significance.  Multiple logistic regressions were 
used to examine the relationships between student characteristics and illicit use of each 
prescription drug.  Interactions between individual level characteristics and nonmedical 
prescription drug use were also examined. 
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RESULTS 
 
Nonmedical Prescription Depressant Use by Student Characteristics 
 
Approximately 4% (n = 57) of college students reported past year use of nonmedical 
prescription CNS depressants.  The average age of depressant users was 20.68 (SD = 2.45), 
indicating that users were slightly younger than nonusers who averaged 21.61 years of age (SD = 
5.12).  White, non-Hispanic students constituted the largest percentage of users with 4.74 (n = 
45) reporting nonmedical depressant use in the last year (See Table 1a).  Approximately 4.49% 
(n = 45) of male students were users, compared to 3.86% (n = 37) of females.  Those living in off 
campus or other housing constituted 4.84% (n = 34) and 5.8% (n = 4) respectively.   
Differences among nonmedical prescription antidepressant users and student 
characteristics (race, age, gender, academic performance (GPA), living arrangement, alcohol and 
other drug usage, and affiliation with a fraternity/sorority) were assessed using Pearson’s χ2 test.  
As illustrated in Table 2, past year use of prescription depressants differed significantly as a 
function of residence (χ2 = 4.33, df = 1, p < 0.05), alcohol (χ2 = 20.43, df = 1, p < 0.05) and 
marijuana use (χ2 = 33.33, df = 1, p < 0.05), and past 14-day binge drinking (χ2 = 6.76, df = 1, P 
< 0.05).  Race, gender, academic performance, and fraternity/sorority affiliation did not 
significantly differ among users and nonusers of prescription CNS depressants.  
 Specifically, those who lived off campus were 2.12 times more likely to use CNS 
depressants nonmedically when compared to students living on campus (95% CI = 1.03, 4.35).  
Additionally, students who reported alcohol use were 4.26 times more likely to use depressants 
compared to students who do not drink (95% CI = 1.32, 13.73).  Students who used marijuana 
(OR = 5.15, 95%CI = 2.79, 9.50) and reported an episode of binge drinking in the past 14 days 
(OR = 3.58, 95% CI = 1.28, 9.98) were also more likely to use depressants (See Table 2).    
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Multiple logistic regression analyses further indicated that college students who lived off 
campus, used alcohol and marijuana in their lifetime was the best predictor of nonmedical 
prescription depressant use (see Table 3).  These students were 4.41 times more likely to use 
depressants than students who lived on campus, and who did not consume alcohol or use 
marijuana (95% CI = 2.28, 8.54).   
Interactions between prescription CNS depressant users and nonusers and student 
characteristics were examined.  There were no statistically significant interactions for past year 
prescription depressant use.  
Nonmedical Prescription Opioid Use by Student Characteristics 
Approximately 11.2% (n = 158) of college students reported past year use of nonmedical 
prescription use of pain killers.  As described in Table 1, the average age of users was 21.81 (SD 
= 5.07) compared to nonusers which was 21.61 (SD = 5.12).  Furthermore, 10.71% (n = 48) of 
males reported prescription opioid use compared to 11.48% (n = 110) of females.  White, non-
Hispanic students constituted 12.3% (n = 117) of users, compared to 10.95% (n = 23) of Black, 
non-Hispanic students.  Approximately 10.24% (n = 39) of students living in campus residence 
halls, 12.36% (n = 87) of off-campus students and 15.49% (n = 11) of other non campus housing 
students reported nonmedical use.  Approximately 11.96% (n = 11) of part time students reported 
nonmedical prescription opioid use, compared to 11.20% (n = 149) of full time students.    
Differences among nonmedical prescription pain killer users and individual 
characteristics (race, gender, academic performance (GPA), living arrangement, alcohol and 
other drug usage, and affiliation with a fraternity/sorority) were assessed using Pearson’s χ2 test.  
Differences among users and nonusers were found to be significant among Asian or 
Pacific/Islanders compared to nonusers (χ2  = 8.50, df = 1, p < 0.05).  Use also different 
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significantly as a function of academic performance (χ2  = 4.80, df = 1, p < 0.05).  Consistent 
with the literature, opioids use differed significantly as a function of lifetime alcohol (χ2  = 12.34, 
df = 1, p < 0.05)  and marijuana use (χ2  = 59.99, df = 1, p < 0.05), and incidence of binge 
drinking (χ2  = 69.72, df = 1, p < 0.05).  Differences among characteristics such as gender, 
residence, and fraternity or sorority affiliation were not found to be significant.  
Asian or Pacific Islander students were less likely to use prescription opioids (OR = 0.35, 
95% CI = (0.17, 0.73) compared to students of a different race/ethnicity (see Table 2).  However, 
students who earned a C or lower GPA (OR = 1.51, 95% CI = 1.04, 2.18), used alcohol (OR = 
2.74, 95% CI = 1.53, 4.92) and marijuana (OR = 3.75, 95% CI = 2.64, 5.33), and those who 
reported an episode of binge drinking in the past 14 days (OR = 2.74, 95% CI = 1.58, 4.73) were 
more likely to use prescription opioids nonmedically.  
However, multiple logistic regression analyses indicated that Asian or Pacific Islander 
students who had a C or lower GPA and reported use of alcohol and marijuana was the best 
predictor of nonmedical prescription opioid use (see Table 3).  These students were 3.25 times 
more likely to use prescription opioids when compared to other students (95% CI = 2.22, 4.78).  
Interactions between student characteristics and nonmedical prescription opioids use 
were examined however none were found to be significant.  
Nonmedical Prescription Stimulant Use by Student Characteristics 
 
Approximately 8.7% (n = 123) of students reported past year use of nonmedical 
prescription use of stimulants.  As noted in Table 1, the average age of nonmedical prescription 
stimulant users was 20.85 (SD = 3.48) compared to 21.70 (SD = 5.27) of nonusers.  Furthermore, 
9.87% (n = 44) of male students reported use, compared to 8.25% (n = 79) of female students.  
Approximately 10.33% (n = 98) of users in the sample were White, non-Hispanic, compared to 
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12.07% (n = 7) of Hispanic students, and 3.81% (n = 8) of Black, non-Hispanic students.  
Additionally, 11.14% (n = 78) of users reported living off campus with 8.99% (n = 117) enrolled 
in the university full time.  
Differences among nonmedical prescription stimulant users and student characteristics 
(race, gender, academic performance (GPA), living arrangement, alcohol and other drug usage, 
and affiliation with a fraternity/sorority) were assessed using Pearson’s χ2 test.  Nonmedical 
prescription stimulant users differed significantly among students reporting White, non-Hispanic 
and African American, non-Hispanic race/ethnicity.  Nonmedical users differed significantly 
between students reporting A GPAs compared to those reporting B or lower averages (See Table 
2).  Nonmedical prescription stimulant users different significantly among students living on or 
off campus, (χ2 = 4.73, df = 1, p <0.05) as well as those living with or without their parents (χ2 = 
4.15, df = 1, p < 0.05).  Consistent with the literature, use was found differ significantly as a 
function alcohol use (χ2 = 23.10, df = 1, p < 0.05).  Marijuana use and past 14 day incidence of 
binge drinking were also noted to differ significantly among users (χ2 = 91.07, df = 1 p < 0.05) 
and (χ2 = 20.46, df = 1, p < 0.05) respectively.  Gender and fraternity/sorority affiliation were not 
statistically significant.  
White, non-Hispanic students were 2.02 times more likely to use prescription stimulants 
(95% CI = 1.28, 3.18) compared to students of a different race/ethnicity (See Table 2).  
However, Black, non-Hispanic students were less likely to use prescription stimulants (OR = 
0.37, 95% CI = 0.18, 0.78).  Students with a B or lower GPA were more likely to use stimulants 
(OR = 1.93, 95% CI = 1.21, 3.08) compared to students earning an A average.  Students living 
off campus (OR = 1.66, 95% CI = 1.05, 2.64) and living off campus without their parents (OR = 
1.84, 95% CI = 1.02, 3.32) were also more likely to use prescription stimulants.  Alcohol users 
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were 10.04 times more likely to use than non users (95% CI = 3.17, 31.83).  Students reporting 
marijuana use (OR = 6.94, 95% CI = 4.43, 10.86) and past 14 day binge drinking (OR = 5.52, 
95% CI = 2.40, 12.75) were also more likely to use prescription stimulants nonmedically.  
The best predictor of nonmedical prescription stimulant use was found to be among 
students who were White, non-Hispanic, had B or lower grade point averages and reported 
alcohol use (OR = 7.96, 95% CI = 2.50, 25.41) (see Table 3).  Furthermore, students who lived 
off campus without their parents and reported alcohol use were significantly more likely to use 
prescription stimulants nonmedically (OR = 7.99, 95% CI = 2.51, 25.47).    
Interactions were examined between the student characteristics investigated however 
there were no statistically significant interactions for past year prescription stimulant use.  
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DISCUSSION 
 
This study found that the past year use of nonmedical prescription depressant, opioids, 
and stimulant use was 4%, 11.2% and 8.7% respectively.  These rates are similar to recent 
studies conducted at other institutions (Garnier et al., 2009; McCabe et al., 2005a, McCabe et at., 
2005b).  Nonmedical use was higher among certain college students, however characteristics 
varied by type of drug.  The student characteristics analyzed in this study provide several 
implications for guiding prevention and intervention efforts as certain characteristics were 
associated with an increased or decreased risk of nonmedical prescription drug use.  More 
importantly, this research suggests that prescription drug interventions should be uniquely 
tailored as the student characteristics associated with use vary across each class of prescription 
drug.   
Specifically, interventions focusing on nonmedical prescription depressant should target 
college students who live off campus, and have used alcohol or marijuana in their lifetime.  
Interventions aimed at reducing opioid use should focus on students who have a C or lower 
average and reported lifetime use of marijuana.  Finally, nonmedical prescription stimulant 
interventions should target students who are White, non-Hispanic with a B or lower grade point 
average.  Additionally, students who lived off campus, without their parents and reported alcohol 
use were significantly more likely to use prescription stimulants nonmedically.  Many of these 
characteristics have been shown in previous studies to be associated with higher rates of 
substance abuse (Garnier et al., 2009; McCabe et al., 2005a; McCabe et al., 2005b). 
Consistent with previous studies, student’s race/ethnicity plays an important role in the 
nonmedical use of prescription drugs.  Stimulant use was found to be much higher among White, 
non-Hispanic college students (McCabe et al., 2005b).   
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Both prescription depressant and stimulant use was associated with student’s residence.  
Students who lived off campus were more likely to use depressants and stimulants nonmedically.  
In previous studies, commuter status was significantly associated with nonmedical prescription 
drug abuse (McCabe, 2008).  Additionally, students who lived off campus without their parents 
were more likely to use stimulants.  These findings are particularly significant, as the university 
has a large commuter population therefore, interventions should be targeted towards this 
population.  
Prior research has indicated that college students often turn to illicit drugs or alcohol in 
response to stress in academic settings (Ford & Schroder, 2008).  These findings support 
previous research as use of prescription opioids and stimulants varied significantly as a function 
of academic performance.  Students with a GPA of a C or lower were significantly more likely to 
use opioids compared to students with a B or lower average who were more likely to use 
prescription stimulants.  This difference may be attributed to reasons for use such as to “get 
high” compared to performance enhancement and should be investigated further to develop more 
tailored interventions.  
Alcohol and other drug use were significantly associated with all three types of 
prescription drugs, supporting the findings of previous studies.  Studies conducted at other 
universities have documented higher rates of prescription drug abuse among students who use 
other substances such as alcohol and marijuana, as well as those who engage in other risky 
behaviors (Garnier, 2009; McCabe, 2005; McCabe, 2008). Furthermore, students who reported 
binge drinking the past 14 days were significantly more likely to abuse prescription drugs.  The 
findings of this study provide compelling evidence that nonmedical users of prescription drugs 
are at substantially higher risk of abusing other types of drugs. 
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The Monitoring the Future Report indicates that males are more likely to use most illicit 
drugs, with the differences seeming to be largest at the higher frequency of use levels (Johntston 
et al., 2009).  Contrary to this report, gender was not found to be significantly associated with 
use of any of the prescription drugs examined in this study.  
Additionally, fraternity or sorority affiliation was not significantly associated with drug 
use.  These findings may be a reflection of the low percentage of students involved in greek 
organizations at this institution and require further investigation.  
Limitations 
 Several limitations prevent conclusive interpretation of the study findings.  The ACHA-
NCHA II consists of data from a web-based survey emailed to participants; therefore the findings 
are subject to the limitations of self-report surveys.  The survey attempted to minimize the bias 
typically associated with self-report surveys instituting certain procedures that past research has 
shown improves the validity and reliability of substance use data collected via self-report 
surveys, including informing the student that participation was voluntary, ensuring anonymity 
and explaining the relevance of the study.  Furthermore, research has documented the 
effectiveness of web-based surveys for college populations (Pealer et al., 2001).  
 The data analyzed were cross-sectional; therefore inferences about the temporal sequence 
of causality between student characteristics and nonmedical prescription drug use could not be 
established.  Furthermore, cross-sectional surveys are often prone to selection bias.  Although the 
response rate was adequate for college surveys, selection bias may impact the interpretation of 
the findings as there may be inherent differences among students who did and did not elect to 
complete the survey.  While selection bias cannot be fully moved, the sample analyzed closely 
matched the demographics of the university, reliving concerns regarding non-response.   
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The sample size for this study was particularly small.  A small sample size has a greater 
probability that the observation was coincidentally particularly good or particularly bad. 
Therefore it is difficult to find significant relationships from the data, as statistical tests typically 
require a larger sample size to justify that the effect was not due to chance alone.  As such, it is 
important not to make strong conclusions about the risk factors identified in this study whether 
the results were positive or not.  However, data from this study should be used to design larger 
confirmatory studies.  
Although rates of nonmedical use were consistent with other findings, additional research 
is needed in diverse settings in order to assess the generality of the findings.  It is important for 
individual institutions to assess prescription drug use among their student population in order to 
create the most effective and appropriate interventions.  
Despite these limitations, this study provides a clear understanding of the overall use of 
nonmedical prescription drugs on campus, as well as identified student characteristics that may 
be useful in future research and interventions.  Though research exists documenting motives for 
use, future analysis should investigate these factors at this particular institution to obtain a more 
accurate and reliable understanding of prescription drug abuse on campus.   
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CONCLUSION 
 As prescription drug abuse rates continue to rise among college students, it is imperative 
that universities identify characteristics and associations with use in order to reduce harm on 
campus.  The information presented in this research will help guide the development of effective 
wellness programs designed to reduce the usage of prescription drug abuse.  This study provides 
valuable information for university administration and health education staff alike.  The results 
from this study will be useful in developing targeted and tailored interventions for prescription 
drug abuse.  The characteristics associated with prescription drug use will help guide health 
promotion campaign decisions.  
As a result of this research, the 2010 survey was modified to include more specific 
questions regarding student’s perceptions of prescription drug abuse on campus, specifically on 
depressants, opioids, and stimulants.  Combined with the findings of this study, future research 
on the impacts of student perceptions and usage may be investigated to implement prescription 
drug abuse into an existing social norms campaign.  
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Mean SD Mean SD
Age 20.68 2.45 21.61 5.12
N Row % N Row %
Race/Ethnicity
White, non-Hispanic 45 4.74% 905 95.26%
Black, non-Hispanic 4 1.91% 205 98.09%
Hispanic or Latino/a 2 3.45% 56 96.55%
Asian or Pacific Islander 6 3.47% 167 96.53%
AI, Alaskan Native, or Native Hawaiian 1 5.88% 16 94.12%
Biracial or Multiracial 1 1.75% 56 98.25%
Other 2 6.25% 30 93.75%
Gender
Male 20 4.49% 425 95.51%
Female 37 3.86% 922 96.14%
Academic Performance
A 15 3.63% 398 96.37%
B 26 3.87% 645 96.13%
C 15 5.02% 284 94.98%
D/F 1 6.67% 14 93.33%
N/A 0 0.00% 12 100.00%
Residence
Campus residence hall 9 2.36% 373 97.64%
Fraternity or sorority house 1 50.00% 1 50.00%
Other college/university housing 0 0.00% 11 100.00%
Parent/guardian's home 9 3.72% 233 96.28%
Other off-campus housing 34 4.84% 669 95.16%
Other 4 5.80% 65 94.20%
Year in School 
1st year undergraduate 18 5.34% 319 94.66%
2nd year undergraduate 10 3.08% 315 96.92%
3rd year undergraduate 8 2.37% 330 97.63%
4th year undergraduate 13 4.63% 268 95.37%
5th year or more undergraduate 8 6.06% 124 93.94%
Enrollment Status
Full time 55 4.22% 1249 95.78%
Part time 2 2.22% 88 97.78%
Other 0 0.00% 13 100.00%
Fraternity or sorority member 
Yes 5 4.67% 102 95.33%
No 52 4.04% 1236 95.96%
Table 1a: Nonmedical Prescription CNS Depressant Users and Nonusers by 
Student Characteristics
Users NonUsers 
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Mean SD Mean SD
Age  21.81 5.07 21.6 5.14
N Row % N Row %
Race/Ethnicity
White, non-Hispanic 117 12.30% 834 87.70%
Black, non-Hispanic 23 10.95% 187 89.05%
Hispanic or Latino/a 5 8.62% 53 91.38%
Asian or Pacific Islander 8 4.62% 165 95.38%
AI, Alaskan Native, or Native Hawaiian 2 11.76% 15 88.24%
Biracial or Multiracial 4 7.02% 53 92.98%
Other 4 10.00% 36 90.00%
Gender
Male 48 10.71% 400 89.29%
Female 110 11.48% 848 88.52%
Academic Performance
A 39 9.40% 376 90.60%
B 72 10.73% 599 89.27%
C 43 14.38% 256 85.62%
D/F 3 20.00% 12 80.00%
N/A 1 8.33% 11 91.67%
Residence
Campus residence hall 39 10.24% 342 89.76%
Fraternity or sorority house 0 0.00% 2 100.00%
Other college/university housing 0 0.00% 11 100.00%
Parent/guardian's home 21 8.68% 221 91.32%
Other off-campus housing 87 12.36% 617 87.64%
Other 11 15.49% 60 84.51%
Year in School 
1st year undergraduate 35 10.42% 301 89.58%
2nd year undergraduate 40 12.35% 284 87.65%
3rd year undergraduate 31 9.12% 309 90.88%
4th year undergraduate 36 12.77% 246 87.23%
5th year or more undergraduate 16 12.03% 117 87.97%
Enrollment Status
Full time 146 11.20% 1158 88.80%
Part time 11 11.96% 81 88.04%
Other 0 0.00% 13 100.00%
Fraternity or sorority member
Yes 12 11.21% 95 88.79%
No 110 8.55% 1177 91.45%
Table 1b: Nonmedical Prescription Opioid Users and Nonusers by Student 
Characteristics
Users NonUsers 
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 Mean SD Mean SD
Age  20.85 3.48 21.7 5.27
N Row % N Row %
Race/Ethnicity
White, non-Hispanic 98 10.33% 851 89.67%
Black, non-Hispanic 8 3.81% 202 96.19%
Hispanic or Latino/a 7 12.07% 51 87.93%
Asian or Pacific Islander 13 7.56% 159 92.44%
AI, Alaskan Native, or Native Hawaiian 1 5.88% 16 94.12%
Biracial or Multiracial 6 10.53% 51 89.47%
Other 7 17.50% 33 82.50%
Gender
Male 44 9.87% 402 90.13%
Female 79 8.25% 878 91.75%
Academic Performance
A 23 5.56% 391 94.44%
B 64 9.57% 605 90.43%
C 34 11.37% 265 88.63%
D/F 2 13.33% 13 86.67%
N/A 0 0.00% 12 100.00%
Residence
Campus residence hall 23 6.02% 359 93.98%
Fraternity or sorority house 1 100.00% 0 0.00%
Other college/university housing 1 9.09% 10 90.91%
Parent/guardian's home 13 5.37% 229 94.63%
Other off-campus housing 78 11.14% 622 88.86%
Other 7 9.86% 64 90.14%
Year in School 
1st year undergraduate 27 8.06% 308 91.94%
2nd year undergraduate 29 8.92% 296 91.08%
3rd year undergraduate 27 7.96% 312 92.04%
4th year undergraduate 28 9.96% 253 90.04%
5th year or more undergraduate 12 9.09% 120 90.91%
Enrollment Status
Full time 117 8.99% 1185 91.01%
Part time 6 6.52% 86 93.48%
Other 0 0.00% 12 100.00%
Fraternity or sorority member 
Yes 12 11.21% 95 88.79%
No 110 38.33% 177 61.67%
Table 1c: Nonmedical Prescription Stimulant Users and Nonusers by 
Student Characteristics
Users NonUsers 
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χ2 p-value OR 95% CI
Residence
   Off-campus housing 4.33 <0.05 2.12 (1.03, 4.35)
Alcohol and Other Drug Use
   Lifetime alcohol use 20.43 <0.05 4.26 (1.32, 13.73)
   Lifetime marijuana use 33.33 <0.05 5.15 (2.79, 9.50)
   Past 14-day binge drinking 6.76 <0.05 3.58 (1.28, 9.98)
Race
   Asian or Pacific Islander 8.50 <0.05 0.35 (0.17, 0.73)
Academic Performance
C or lower average 4.80 <0.05 1.51 (1.04, 2.18)
Alcohol and Other Drug Use
   Lifetime alcohol use 12.34 <0.05 2.74 (1.53, 4.92)
   Lifetime marijuana use 59.99 <0.05 3.75 (2.64, 5.33)
   Past 14-day binge drinking 69.72 <0.05 2.74 (1.58, 4.73)
Race
   White, non-Hispanic 9.50 <0.05 2.02 (1.28, 3.18)
   Black, non-Hispanic 7.45 <0.05 0.37 (0.18, 0.78)
Academic Performance
B or lower average 7.74 <0.05 1.93 (1.21, 3.08)
Residence
   Off-campus housing 4.73 <0.05 1.66 (1.05, 2.64)
   Does not live with parents 4.15 <0.05 1.84 (1.02, 3.32)
Alcohol or Other Drug Use
   Lifetime alcohol use 23.10 <0.05 10.04 (3.17, 31.83)
   Lifetime marijuana use 91.07 <0.05 6.94 (4.43, 10.86)
   Past 14-day binge drinking 20.46 <0.05 5.52 (2.40, 12.75)
Nonmedical CNS Depressant Use
Nonmedical Opioid Use
Nonmedical Stimulant Use
*The results for student characteristics that were not significantly associated (p > 
0.05) with past year nonmedical use of prescription drugs are not shown. 
Table 2: Bivariate Analyses: Student Characteristics and Nonmedical 
Prescription Drug Use
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OR 95% CI p-value
Residence
   Off campus housing 2.12 (1.03, 4.35) <0.05
Alcohol and Other Drug Use
   Lifetime alcohol use 3.91 (1.21, 12.64) <0.05
   Lifetime marijuana use 4.41 (2.28, 8.54) <0.05
Race
   Asian or Pacific Islander 0.35 (0.17, 0.73) <0.05
Academic Performance
   C or lower average 1.50 (1.03, 2.17) <0.05
Alcohol and Other Drug Use
   Lifetime marijuana use 3.25 (2.22, 4.78) <0.05
   Past 14-day binge drinking 1.65 (2.15, 4.67) <0.05
Race 
   White, non-Hispanic 2.02 (1.28, 3.30) <0.05
Academic Performance 
   B or lower average 2.06 1.28, 3.30 <0.05
Residence
   Live without parents 2.00 (1.10, 3.63) <0.05
Alcohol and Other Drug Use
   Lifetime alcohol use 7.96 (2.50, 25.41) <0.05
   Lifetime marijuana use 5.04 (3.15, 8.07) <0.05
Race 
Black, non-Hispanic 0.37 (0.18, 0.78) <0.05
Academic Performance 
   B or lower average 2.09 (1.30, 3.34) <0.05
Residence
   Live without parents 1.96 (1.08, 3.55) <0.05
Alcohol and Other Drug Use
   Lifetime alcohol use 8.79 (2.76, 27.96) <0.05
   Lifetime marijuana use 5.05 (3.16, 8.07) <0.05
*The results for student characteristics that were not significantly 
associated (p > 0.05) with past year nonmedical use of prescription 
drugs are not shown. 
Table 3: Logistic Regression Analysis: Student Characteristics 
and Nonmedical Prescription Drug Use 
Nonmedical CNS Depressant Use
Nonmedical Opioid Use
Nonmedical Stimulant Use
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